Sign inJoin waitlistJoin the waitlist

Max Kates

Physician · Johns Hopkins School of Medicine

Credentials: · · ·

History

Johns Hopkins School of Medicine
Present

Urology
2014–2019
Icahn School of Medicine at Mount Sinai
2008–2012

Research

Multi-Institution Evaluation of Sequential Gemcitabine and Docetaxel as Rescue Therapy for Nonmuscle Invasive Bladder Cancer
The Journal of Urology · 2020 · 165 citations
Survival following lobectomy and limited resection for the treatment of stage I non-small cell lung cancer<=1 cm in size: a review of SEER data
Chest · 2011 · First of 3 authors · 164 citations
Expression of Nectin-4 in Bladder Urothelial Carcinoma, in Morphologic Variants, and Nonurothelial Histotypes
Applied immunohistochemistry & molecular morphology · 2021 · 145 citations

TB
Trinity Bivalacqua
89 papers · 39 as a resident
NH
Noah Hahn
39 papers
Andres Matoso
32 papers
Phillip Pierorazio
28 papers · 1 as a resident
Sunil Patel
25 papers · 7 as a resident
JH
Jean Hoffman-Censits
21 papers
NS
Nikolai Sopko
21 papers · 18 as a resident
Meera Chappidi
20 papers · 6 as a resident
Alexander Baras
19 papers
James McKiernan
19 papers
Mark Schoenberg
18 papers
Hiten Patel
15 papers · 9 as a resident

Clinical trials

Home Intravenous Fluid Infusion After Undergoing Radical Cystectomy
Principal investigator · Recruiting
Johns Hopkins University
2025–2028
A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT
Principal investigator · Active not recruiting · Phase 3
CG Oncology, Inc.
2023–2029
Intravesical Gemcitabine and Docetaxel for BCG naïve Non-muscle Invasive Bladder Cancer
Principal investigator · Active not recruiting · Phase 2
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
2020–2026
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
Site PI · Recruiting · Phase 3
Alliance for Clinical Trials in Oncology
2025–2028